Viagra experienced no impact on saquinavir pharmacokinetics. A more robust CYP3A4 inhibitor like ketoconazole or itraconazole can be anticipated to obtain higher impact than that observed with saquinavir. Population pharmacokinetic information from patients in medical trials also indicated a discount in sildenafil clearance when it had been co-admi